Altre lingue Zhaoke Ophthalmology Limited

Azioni

6622

KYG989M51017

Mercato chiuso - Hong Kong S.E. Altri mercati azionari 10:08:07 05/07/2024			Variaz. 5gg	Var. 1 gen.
1,41 ^HKD	-0,70%		0,00%	-64,30%

04/07	Zhaoke Ophthalmology concede 4,6 milioni di opzioni azionarie	MT
29/04	Zhaoke Ophthalmology riduce la perdita nel 2023	MT

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Hong Kong Stocks Rally on US Rate Cut Hopes, EU's Indecisive on Tariffs on Chinese EVs	04/07
Zhaoke Ophthalmology Grants 4.6 Million Share Options	04/07
Zhaoke Ophthalmology Shrinks Loss in 2023	29/04
Zhaoke Ophthalmology Limited Announces the Resignation of Chen Yu Has as Non-Executive Director	08/04
Zhaoke Ophthalmology Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Zhaoke Ophthalmology Grants Kwangdong Pharma Rights to Distribute Eye Drop in Korea	29/01
Zhaoke Ophthalmology's Investigational New Drug Applications for Pupil-Modulating Eye Drops Given Green Light by Chinese Regulator	24/01
Zhaoke Ophthalmology Limited Announces Investigational New Drug Applications for Clinical Trial of Brimachol PF for the Treatment of Presbyopia	24/01
Zhaoke Ophthalmology Limited Announces Executive Changes	27/11
Lee’s Pharmaceutical Sells Rights for Eyprotor to Zhaoke Ophthalmology for 60 Million Yuan	14/11
Zhaoke Ophthalmology's Myopia Treatment Shows Strong Safety, Efficacy in Phase 3 Study	13/10/23
Zhaoke Ophthalmology Limited Announces Positive Top-Line Results from NVK002 One-Year Phase III Clinical Trial (Mini-Champ) in China for the Treatment of Myopia Progress in Children and Adoption in China	13/10/23
Zhaoke Ophthalmology Enlists Patients for 2 Drug Trials; Will Refile NDA for Eye Gel	03/10/23
Zhaoke Ophthalmology Limited Provides Updates on Phase III Clinical Trials for Tab014 and Epinastine Hcl and Update on the New Drug Application for Cyclosporine A Ophthalmic Gel	03/10/23
Zhaoke Ophthalmology's Loss Widens in H1	24/08/23
Zhaoke Ophthalmology Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23/08/23
Zhaoke Ophthalmology Concludes Phase III Trial of Myopia Medication	10/08/23
Zhaoke Ophthalmology Limited Announces Completion of NVK002 Phase III Bridging Clinical Trial	09/08/23
Zhaoke Ophthalmology Enters into Exclusive License, Supply and Distribution Agreement with Eyedetec Medical to Commercialize Eye Lipid Mobilizer for the Treatment of Dry Eye Disease	08/06/23
US FDA Approves New Drug Application of Zhaoke Ophthalmology's Eye Drops for Nearsightedness; Shares Surge 12%	07/06/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Zhaoke Ophthalmology Limited

Azioni

6622

KYG989M51017

Altre lingue

Filtri